🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00355121
The aim of the study is to assess safety and immunogenicity of a single dos...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01642589
The purpose of this study was to evaluate the immunogenicity and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00777257
The aim of the study is to further characterize the safety and immunogenici...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01659996
Treatments Being Tested
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-22
Trial ID
NCT02199691
Treatments Being Tested